Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Patient-prosthesis mismatch in new generation trans-catheter heart valves: a propensity score analysis.

Theron A, Pinto J, Grisoli D, Griffiths K, Salaun E, Jaussaud N, Ravis E, Lambert M, Messous L, Amanatiou C, Cuisset T, Gariboldi V, Giorgi R, Habib G, Collart F.

Eur Heart J Cardiovasc Imaging. 2018 Feb 1;19(2):225-233. doi: 10.1093/ehjci/jex019.

PMID:
28329317
2.

Comparison of SAPIEN 3 and SAPIEN XT transcatheter heart valve stent-frame expansion: evaluation using multi-slice computed tomography.

Kazuno Y, Maeno Y, Kawamori H, Takahashi N, Abramowitz Y, Babak H, Kashif M, Chakravarty T, Nakamura M, Cheng W, Friedman J, Berman D, Makkar RR, Jilaihawi H.

Eur Heart J Cardiovasc Imaging. 2016 Sep;17(9):1054-62. doi: 10.1093/ehjci/jew032. Epub 2016 Mar 21.

3.

Comparison between the SAPIEN S3 and the SAPIEN XT transcatheter heart valves: A single-center experience.

Sawaya FJ, Spaziano M, Lefèvre T, Roy A, Garot P, Hovasse T, Neylon A, Benamer H, Romano M, Unterseeh T, Morice MC, Chevalier B.

World J Cardiol. 2016 Dec 26;8(12):735-745. doi: 10.4330/wjc.v8.i12.735.

4.

Transcatheter aortic valve implantation with the new balloon-expandable Sapien 3 versus Sapien XT valve system: a propensity score-matched single-center comparison.

Nijhoff F, Abawi M, Agostoni P, Ramjankhan FZ, Doevendans PA, Stella PR.

Circ Cardiovasc Interv. 2015 Jun;8(6):e002408. doi: 10.1161/CIRCINTERVENTIONS.115.002408.

PMID:
26033967
5.

Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart Valves.

Binder RK, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Pedrazzini G, Amann FW, Ferrari E, Noble S, Nietlispach F, Maisano F, Räber L, Roffi M, Grünenfelder J, Jüni P, Huber C, Windecker S, Wenaweser P.

Circ Cardiovasc Interv. 2015 Oct;8(10). pii: e002653. doi: 10.1161/CIRCINTERVENTIONS.115.002653.

6.

Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve.

Tarantini G, Mojoli M, Purita P, Napodano M, D'Onofrio A, Frigo A, Covolo E, Facchin M, Isabella G, Gerosa G, Iliceto S.

EuroIntervention. 2015 Jul;11(3):343-50. doi: 10.4244/EIJY14M11_06.

7.

Multidetector CT predictors of prosthesis-patient mismatch in transcatheter aortic valve replacement.

Freeman M, Webb JG, Willson AB, Wheeler M, Blanke P, Moss RR, Thompson CR, Munt B, Norgaard BL, Yang TH, Min JK, Poulsen S, Hansson NC, Binder RK, Toggweiler S, Hague C, Wood DA, Pibarot P, Leipsic J.

J Cardiovasc Comput Tomogr. 2013 Jul-Aug;7(4):248-55. doi: 10.1016/j.jcct.2013.08.005. Epub 2013 Aug 23.

PMID:
24148778
8.

Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.

Binder RK, Webb JG, Toggweiler S, Freeman M, Barbanti M, Willson AB, Alhassan D, Hague CJ, Wood DA, Leipsic J.

JACC Cardiovasc Interv. 2013 May;6(5):462-8. doi: 10.1016/j.jcin.2012.12.128.

9.

Early Safety and Efficacy of Sapien 3 20 mm Transcatheter Heart Valve Implantation in Small Japanese Body Size.

Meguro K, Kakizaki R, Hashimoto T, Yanagisawa T, Koitabashi T, Kitamura T, Ako J.

Heart Surg Forum. 2018 Aug 14;21(5):E341-E344. doi: 10.1532/hsf.1918.

PMID:
30311882
10.

Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT.

Yang TH, Webb JG, Blanke P, Dvir D, Hansson NC, Nørgaard BL, Thompson CR, Thomas M, Wendler O, Vahanian A, Himbert D, Kodali SK, Hahn RT, Thourani VH, Schymik G, Precious B, Berger A, Wood DA, Pibarot P, Rodés-Cabau J, Jaber WA, Leon MB, Walther T, Leipsic J.

JACC Cardiovasc Interv. 2015 Mar;8(3):462-471. doi: 10.1016/j.jcin.2014.10.014. Erratum in: JACC Cardiovasc Interv. 2015 May;8(6):876.

11.

Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.

Baron SJ, Thourani VH, Kodali S, Arnold SV, Wang K, Magnuson EA, Pichard AD, Babaliaros V, George I, Miller DC, Tuzcu EM, Greason K, Herrmann HC, Smith CR, Leon MB, Cohen DJ; PARTNER 2 Investigators.

JACC Cardiovasc Interv. 2018 Jun 25;11(12):1188-1198. doi: 10.1016/j.jcin.2018.02.032. Epub 2018 May 30.

PMID:
29860075
12.

No clinical effect of prosthesis-patient mismatch after transcatheter versus surgical aortic valve replacement in intermediate- and low-risk patients with severe aortic valve stenosis at mid-term follow-up: an analysis from the NOTION trial.

Thyregod HG, Steinbrüchel DA, Ihlemann N, Ngo TA, Nissen H, Kjeldsen BJ, Chang Y, Hansen PB, Olsen PS, Søndergaard L.

Eur J Cardiothorac Surg. 2016 Oct;50(4):721-728. Epub 2016 Mar 22.

PMID:
27005980
13.

Comparison of 1-Year Survival and Frequency of Paravalvular Leakage Using the Sapien 3 Versus the Sapien XT for Transcatheter Aortic Valve Implantation for Aortic Stenosis.

Meyer A, Unbehaun A, Hamandi M, Sündermann SH, Buz S, Klein C, Stamm C, Falk V, Kempfert J.

Am J Cardiol. 2017 Dec 15;120(12):2247-2255. doi: 10.1016/j.amjcard.2017.08.049. Epub 2017 Oct 9.

PMID:
29103606
14.

Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves.

Toggweiler S, Wood DA, Rodés-Cabau J, Kapadia S, Willson AB, Ye J, Cheung A, Leipsic J, Binder RK, Gurvitch R, Freeman M, Thompson CR, Svensson LG, Dumont E, Tuzcu EM, Webb JG.

JACC Cardiovasc Interv. 2012 May;5(5):571-577. doi: 10.1016/j.jcin.2012.03.008.

15.

Indexed effective orifice area is a significant predictor of higher mid- and long-term mortality rates following aortic valve replacement in patients with prosthesis-patient mismatch.

Chen J, Lin Y, Kang B, Wang Z.

Eur J Cardiothorac Surg. 2014 Feb;45(2):234-40. doi: 10.1093/ejcts/ezt245. Epub 2013 May 16. Review.

PMID:
23682010
16.

Incidence and impact of prosthesis-patient mismatch after transcatheter aortic valve implantation.

Bleiziffer S, Hettich I, Hutter A, Wagner A, Deutsch MA, Piazza N, Lange R.

J Heart Valve Dis. 2013 May;22(3):309-16.

PMID:
24151756
17.

Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height.

De Torres-Alba F, Kaleschke G, Diller GP, Vormbrock J, Orwat S, Radke R, Reinke F, Fischer D, Reinecke H, Baumgartner H.

JACC Cardiovasc Interv. 2016 Apr 25;9(8):805-813. doi: 10.1016/j.jcin.2015.12.023. Epub 2016 Mar 23.

18.

Hemodynamic characteristics of Edwards Sapien aortic valve prosthesis assessed with transesophageal echocardiography.

Kukucka M, Pasic M, Unbehaun A, Dreysse S, Mladenow A, Habazettl H, Hetzer R.

J Heart Valve Dis. 2012 Sep;21(5):662-9.

PMID:
23167233
19.

Self-expanding Portico Valve Versus Balloon-expandable SAPIEN XT Valve in Patients With Small Aortic Annuli: Comparison of Hemodynamic Performance.

Del Trigo M, Dahou A, Webb JG, Dvir D, Puri R, Abdul-Jawad Altisent O, Campelo-Parada F, Thompson C, Leipsic J, Stub D, DeLarochellière R, Paradis JM, Dumont E, Doyle D, Mohammadi S, Pasian S, Côté M, Pibarot P, Rodés-Cabau J.

Rev Esp Cardiol (Engl Ed). 2016 May;69(5):501-8. doi: 10.1016/j.rec.2015.08.019. Epub 2015 Dec 29. English, Spanish.

PMID:
26739827
20.

Impact of institutional volume and experience with CT interpretation on sizing of transcatheter aortic valves: A multicenter retrospective study.

Verma DR, Pershad Y, Pershad A, Fang K, Gellert G, Morris MF.

Cardiovasc Revasc Med. 2016 Dec;17(8):566-570. doi: 10.1016/j.carrev.2016.08.007. Epub 2016 Aug 27.

PMID:
27641485

Supplemental Content

Support Center